Current status of hematopoietic stem cell transplant in chronic myeloid leukemia

Indications for hematopoietic stem cell transplant (HSCT) in chronic myeloid leukemia (CML) have changed over time. This change has largely been influenced by the advent of tyrosine kinase inhibitors, increased understanding of the mechanisms underlying disease phase progression as well as drug resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Alok, Khattry, Navin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202616/
https://www.ncbi.nlm.nih.gov/pubmed/25336791
http://dx.doi.org/10.4103/0971-5851.142036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202616/
https://www.ncbi.nlm.nih.gov/pubmed/25336791
http://dx.doi.org/10.4103/0971-5851.142036

Ejemplares similares